752596
Last Update Posted: 2017-02-01
Recruiting has ended
Males accepted | Under |
1 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient
This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.
Eligibility
Relevant conditions:
Congestive Heart Failure
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov